drugset / Trial / NCT01550341
HIV, Buprenorphine, and the Criminal Justice System
Completed
50 enrolled
Yale University
George Mason University · collabHoward University · collabNational Institute on Drug Abuse (NIDA) · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The aims of STRIDE were changed as of July, 2014. The revised project, called STRIDE2, has a longitudinal, non-randomized, observational study design. The population under study consists of individuals living with HIV who are dependent on opioids.
Timeline
- Start
- 2012-02-23
- Primary completion
- 2015-11-30
- Completion
- 2016-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Buprenorphine | Other / unclassified | 2 mg | Other |
| Comparator | Buprenorphine | Other / unclassified | 8 mg | Other |
| Comparator | Naloxone | Small molecule | 0.5 mg | Other |
| Comparator | Naloxone | Small molecule | 2 mg | Other |